CompoAtlas

GNC TriFlex

Natural health product licensed in Canada

Licence holder
GNC Canada Holdings ULC
NPN or DIN-HM
80031509
Status
Inactive licence
Licence date
18 April 2012
Revision date
Not provided
Form
Comprimé
Route of administration
Orale
Application type
Non traditionnelle

If this product were sold in France

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Zingiber officinale

Source : Rhizome

12.5 mgNot calculated
Salix alba

Source : Écorce

Potency : 15 % salicin

25 mgNot calculated
Sulfate de chondroïtine

Source : Cartilage de bovin

400 mgNot calculated

Non-medicinal ingredients

Microcrystalline cellulose, Maltodextrine, Stéarate de magnésium, Hypromellose, Dioxyde de silicium

PopulationAgeQuantity per servingFrequency
AdultesNot specified1 Comprimé3 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

A factor in maintaining healthy cartilage. Helps to maintain healthy cartilage. A factor in maintaining joint health. Helps to maintain joint health. Helps to relieve joint pain associated with osteoarthritis. Helps to relieve pain associated with osteoarthritis of the knee. Used in Herbal Medicine as an anti-inflammatory to help relieve joint pain.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Source

Official Health Canada record, licence 80031509

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line